Recombinant Human ATXN7 Protein，His

ATXN7, or Ataxin-7, is a protein encoded by the ATXN7 gene, which is part of the polyglutamine (polyQ) expansion family associated with several neurodegenerative diseases, particularly spinocerebellar ataxia type 7 (SCA7). This condition is characterized by motor dysfunction, vision problems, and progressive neurological decline. The research on ATXN7 recombinant protein has gained prominence in the field of molecular biology due to its implications in understanding the pathogenesis of polyQ disorders. ATXN7 is known to interact with various cellular proteins and play a significant role in transcriptional regulation, and the presence of an extended polyQ tract in patients leads to the misfolding and aggregation of this protein, contributing to neurotoxicity. Studies involving recombinant ATXN7 focus on elucidating the structure-function relationship of the protein, its aggregation pathway, and the cellular mechanisms underlying SCA7. Furthermore, the recombinant form of ATXN7 serves as a vital tool for investigating potential therapeutic strategies aimed at mitigating the disease's symptoms. Understanding ATXN7's functional dynamics and its pathological variants could pave the way for the development of targeted interventions and provide insights into broader neurodegenerative processes linked to polyglutamine expansions. As such, the study of ATXN7 not only enhances our comprehension of SCA7 but also contributes to the overarching goal of developing effective treatments for polyQ-related disorders.